Verastem, Inc. (VSTM)
9.995
-0.12
(-1.24%)
USD |
NASDAQ |
Dec 10, 16:00
9.995
0.00 (0.00%)
After-Hours: 20:00
Verastem Research and Development Expense (Quarterly): 28.99M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| Anavex Life Sciences Corp. | 7.295M |
| Ocugen, Inc. | 10.20M |
| Syndax Pharmaceuticals, Inc. | 56.28M |
| AnaptysBio, Inc. | 31.27M |